Spark Therapeutics IPO Research Information

Spark Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Spark Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Spark Therapeutics	ONCE - NASDAQ	$15.00-$17.00	$23.00	$45.10	7 million	1/30/2015
Underwriter(s): J.P. Morgan, Credit Suisse
Co-Manager(s): Cowen and Company, Sanford C. Bernstein
Industry: Health Care
Filing(s): Filed 2014-12-30 Terms Added 2015-01-20

Spark Therapeutics Quote & Chart - Click for current quote - ONCE

About Spark Therapeutics (adapted from Spark Therapeutics prospectus):
They are a leader in the field of gene therapy, seeking to transform the lives of patients suffering from debilitating genetic diseases by developing one-time, life-altering treatments.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ONCE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.